Screening compounds for Malaria drug discovery

Status
Completed
Start date
End date
Start stage
Screening
End stage
Screening
Disease
Malaria
Research areas
Drug

Resistance to current antimalarial drugs is a serious problem. New therapeutics with novel mechanisms of action are needed to curtail the suffering caused by malaria. Preliminary data from Dr. Gilbert and others suggested that a certain class of compounds might have antimalarial properties. Eisai shared proprietary compounds of that class with Dr. Gilbert to screen for activity against Malaria parasites.